This Biotech Stock Soared: Why One Fund Sold $3 Million
A biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
Examines historic SP 500 downturns affecting retirees, highlighting lessons for risk management and smarter, longer-term retirement strategies.
28,497 articlesA biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
When rates trend downward, cash-flow investors face a tougher math as prices rise and competition heats up. This guid...
Microsoft stock is drawing fresh attention as investors weigh AI demand against execution risk. With a trailing P/E n...
Greg Abel’s early moves at Berkshire Hathaway signal a new investment ethos. This analysis breaks down the rationale,...
When wealth and fame meet legal drama, discovery battles can reshape costs and outcomes. This article breaks down the...
Patience and a long time horizon are the most powerful tools in any investor’s kit. This guide explains why waiting f...
RLJ Lodging Trust has fallen about 8% over the last 12 months. Yet a sizeable stake by a key investor suggests there ...
A once-hot cybersecurity stock has fallen 40%, yet a large investor just increased exposure. This guide breaks down w...
Investors watched spacemobile stock crushed thursday move sharply as AT&T, Verizon, and T-Mobile signaled a bold sate...
As Warren Buffett steps back, Greg Abel’s potential move to buy a stock Buffett loves has investors buzzing. This art...
A Florida fraud case reveals how a Medicare supplier study spiraled into a $3.76 billion misbilling crisis. This arti...
A biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...